Hubei Hongyuan Pharmaceutical Technology Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Shuangxi Xu
Chief executive officer
CN¥516.2k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 6.6% |
| Management average tenure | no data |
| Board average tenure | 1.5yrs |
Recent management updates
Recent updates
Subdued Growth No Barrier To Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SZSE:301246) With Shares Advancing 38%
Oct 08
Hubei Hongyuan Pharmaceutical Technology Co., Ltd.'s (SZSE:301246) P/S Still Appears To Be Reasonable
Aug 23Hubei Hongyuan Pharmaceutical Technology's (SZSE:301246) Soft Earnings Are Actually Better Than They Appear
Apr 29Getting In Cheap On Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SZSE:301246) Is Unlikely
Mar 14CEO
Shuangxi Xu (58 yo)
no data
Tenure
CN¥516,200
Compensation
Mr. Xu Shuangxi serves as Director and General Manager at Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director and General Manager | no data | CN¥516.20k | 6.62% CN¥ 433.7m | |
| Deputy GM & Non-Independent Director | 1.5yrs | CN¥701.20k | 1.14% CN¥ 74.8m | |
| Deputy GM & Non-Independent Director | 1.5yrs | CN¥423.20k | 0.63% CN¥ 41.5m | |
| Chairman of the Board | no data | CN¥651.10k | 22.75% CN¥ 1.5b | |
| Supervisor | no data | no data | 1.74% CN¥ 113.8m | |
| Chairman of Supervisory Board | no data | no data | 1.51% CN¥ 98.9m | |
| Independent Director | 1.5yrs | CN¥44.30k | no data | |
| Independent Director | 1.5yrs | CN¥44.30k | no data | |
| Independent Director | 1.5yrs | CN¥44.30k | no data | |
| Vice Chairman of the Board | 1.5yrs | CN¥382.20k | no data | |
| Non-Employee Supervisor | 1.5yrs | no data | 1.44% CN¥ 94.6m |
1.5yrs
Average Tenure
58yo
Average Age
Experienced Board: 301246's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.